Financial Metrics

RMD RESMED INC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.64	—	USD/shares	10-Q	2017-04-28
Quarterly	2016-09-30	0.54	-15.6%	USD/shares	10-Q	2017-10-27
Quarterly	2016-12-31	0.54	+0.0%	USD/shares	10-Q	2018-01-24
Quarterly	2017-03-31	0.62	+14.8%	USD/shares	10-Q	2018-04-27
Quarterly	2017-09-30	0.6	-3.2%	USD/shares	10-Q	2018-10-26
Quarterly	2017-12-31	0.07	-88.3%	USD/shares	10-Q	2019-02-01
Quarterly	2018-03-31	0.76	+985.7%	USD/shares	10-Q	2019-05-03
Quarterly	2018-09-30	0.73	-3.9%	USD/shares	10-Q	2019-10-25
Quarterly	2018-12-31	0.86	+17.8%	USD/shares	10-Q	2020-01-31
Quarterly	2019-03-31	0.73	-15.1%	USD/shares	10-Q	2020-05-01
Quarterly	2019-09-30	0.83	+13.7%	USD/shares	10-Q	2020-10-30
Quarterly	2019-12-31	1.1	+32.5%	USD/shares	10-Q	2021-01-29
Quarterly	2020-03-31	1.12	+1.8%	USD/shares	10-Q	2021-04-30
Quarterly	2020-09-30	1.22	+8.9%	USD/shares	10-Q	2021-10-29
Quarterly	2020-12-31	1.23	+0.8%	USD/shares	10-Q	2022-01-28
Quarterly	2021-03-31	-0.54	-143.9%	USD/shares	10-Q	2022-04-29
Quarterly	2021-09-30	1.39	+357.4%	USD/shares	10-Q	2022-10-28
Quarterly	2021-12-31	1.37	-1.4%	USD/shares	10-Q	2023-01-27
Quarterly	2022-03-31	1.22	-10.9%	USD/shares	10-Q	2023-04-28
Quarterly	2022-09-30	1.43	+17.2%	USD/shares	10-Q	2023-10-27
Quarterly	2022-12-31	1.53	+7.0%	USD/shares	10-Q	2024-01-25
Quarterly	2023-03-31	1.58	+3.3%	USD/shares	10-Q	2024-04-26
Quarterly	2023-09-30	1.49	-5.7%	USD/shares	10-Q	2024-10-25
Quarterly	2023-12-31	1.42	-4.7%	USD/shares	10-Q	2025-01-31
Quarterly	2024-03-31	2.04	+43.7%	USD/shares	10-Q	2025-04-24
Quarterly	2024-09-30	2.11	+3.4%	USD/shares	10-Q	2025-10-31
Quarterly	2024-12-31	2.34	+10.9%	USD/shares	10-Q	2026-01-30
Quarterly	2025-03-31	2.48	+6.0%	USD/shares	10-Q	2025-04-24
Quarterly	2025-09-30	2.37	-4.4%	USD/shares	10-Q	2025-10-31
Quarterly	2025-12-31	2.68	+13.1%	USD/shares	10-Q	2026-01-30
Annual	2016-06-30	2.49	—	USD/shares	10-K	2018-08-17
Annual	2017-06-30	2.4	-3.6%	USD/shares	10-K	2019-08-08
Annual	2018-06-30	2.19	-8.8%	USD/shares	10-K	2020-08-13
Annual	2019-06-30	2.8	+27.9%	USD/shares	10-K	2021-08-17
Annual	2020-06-30	4.27	+52.5%	USD/shares	10-K	2022-08-12
Annual	2021-06-30	3.24	-24.1%	USD/shares	10-K	2023-08-11
Annual	2022-06-30	5.3	+63.6%	USD/shares	10-K	2024-08-09
Annual	2023-06-30	6.09	+14.9%	USD/shares	10-K	2025-08-08
Annual	2024-06-30	6.92	+13.6%	USD/shares	10-K	2025-08-08
Annual	2025-06-30	9.51	+37.4%	USD/shares	10-K	2025-08-08

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	435609000.0	—	USD	10-Q	2016-04-29
Quarterly	2016-06-30	873332000.0	+100.5%	USD	10-Q	2017-04-28
Quarterly	2016-09-30	873511000.0	+0.0%	USD	10-Q	2016-10-28
Quarterly	2016-12-31	868690000.0	-0.6%	USD	10-Q	2017-01-25
Quarterly	2017-03-31	1168350000.0	+34.5%	USD	10-Q	2017-04-28
Quarterly	2017-06-30	1078611000.0	-7.7%	USD	10-Q	2018-04-27
Quarterly	2017-09-30	1018871000.0	-5.5%	USD	10-Q	2017-10-27
Quarterly	2018-03-31	810000000.0	-20.5%	USD	10-Q	2018-04-27
Quarterly	2018-06-30	269988000.0	-66.7%	USD	10-Q	2019-05-03
Quarterly	2018-09-30	517637000.0	+91.7%	USD	10-Q	2018-10-26
Quarterly	2018-12-31	1185500000.0	+129.0%	USD	10-Q	2019-02-01
Quarterly	2019-03-31	1323349000.0	+11.6%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	1258861000.0	-4.9%	USD	10-Q	2020-05-01
Quarterly	2019-09-30	1208210000.0	-4.0%	USD	10-Q	2019-10-25
Quarterly	2019-12-31	1287509000.0	+6.6%	USD	10-Q	2020-01-31
Quarterly	2020-03-31	1364849000.0	+6.0%	USD	10-Q	2020-05-01
Quarterly	2020-06-30	1164133000.0	-14.7%	USD	10-Q	2021-04-30
Quarterly	2020-09-30	1044435000.0	-10.3%	USD	10-Q	2020-10-30
Quarterly	2020-12-31	813732000.0	-22.1%	USD	10-Q	2021-01-29
Quarterly	2021-03-31	719046000.0	-11.6%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	643351000.0	-10.5%	USD	10-Q	2022-04-29
Quarterly	2021-09-30	793668000.0	+23.4%	USD	10-Q	2021-10-29
Quarterly	2021-12-31	667979000.0	-15.8%	USD	10-Q	2022-01-28
Quarterly	2022-03-31	668735000.0	+0.1%	USD	10-Q	2022-04-29
Quarterly	2022-06-30	765325000.0	+14.4%	USD	10-Q	2023-04-28
Quarterly	2022-09-30	785436000.0	+2.6%	USD	10-Q	2022-10-28
Quarterly	2022-12-31	1790689000.0	+128.0%	USD	10-Q	2023-01-27
Quarterly	2023-03-31	1575963000.0	-12.0%	USD	10-Q	2023-04-28
Quarterly	2023-06-30	1431234000.0	-9.2%	USD	10-Q	2024-04-26
Quarterly	2023-09-30	1351511000.0	-5.6%	USD	10-Q	2023-10-27
Quarterly	2023-12-31	1216769000.0	-10.0%	USD	10-Q	2024-01-25
Quarterly	2024-03-31	997047000.0	-18.1%	USD	10-Q	2024-04-26
Quarterly	2024-06-30	697313000.0	-30.1%	USD	10-Q	2025-04-24
Quarterly	2024-09-30	667578000.0	-4.3%	USD	10-Q	2024-10-25
Quarterly	2024-12-31	662859000.0	-0.7%	USD	10-Q	2025-01-31
Quarterly	2025-03-31	663126000.0	+0.0%	USD	10-Q	2025-04-24
Quarterly	2025-06-30	658392000.0	-0.7%	USD	10-Q	2026-01-30
Quarterly	2025-09-30	408661000.0	-37.9%	USD	10-Q	2025-10-31
Quarterly	2025-12-31	403923000.0	-1.2%	USD	10-Q	2026-01-30
Annual	2016-06-30	873332000.0	—	USD	10-K	2017-08-04
Annual	2017-06-30	1078611000.0	+23.5%	USD	10-K	2018-08-17
Annual	2018-06-30	269988000.0	-75.0%	USD	10-K	2019-08-08
Annual	2019-06-30	1258861000.0	+366.3%	USD	10-K	2020-08-13
Annual	2020-06-30	1164133000.0	-7.5%	USD	10-K	2021-08-17
Annual	2021-06-30	643351000.0	-44.7%	USD	10-K	2022-08-12
Annual	2022-06-30	765325000.0	+19.0%	USD	10-K	2023-08-11
Annual	2023-06-30	1431234000.0	+87.0%	USD	10-K	2024-08-09
Annual	2024-06-30	697313000.0	-51.3%	USD	10-K	2025-08-08
Annual	2025-06-30	658392000.0	-5.6%	USD	10-K	2025-08-08

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	44133000.0	—	USD	10-Q	2017-04-28
Quarterly	2016-09-30	14560000.0	-67.0%	USD	10-Q	2017-10-27
Quarterly	2016-12-31	29247000.0	+100.9%	USD	10-Q	2018-01-24
Quarterly	2017-03-31	43857000.0	+50.0%	USD	10-Q	2018-04-27
Quarterly	2017-09-30	16030000.0	-63.4%	USD	10-Q	2018-10-26
Quarterly	2017-12-31	32000000.0	+99.6%	USD	10-Q	2019-02-01
Quarterly	2018-03-31	44961000.0	+40.5%	USD	10-Q	2019-05-03
Quarterly	2018-09-30	12994000.0	-71.1%	USD	10-Q	2019-10-25
Quarterly	2018-12-31	31425000.0	+141.8%	USD	10-Q	2020-01-31
Quarterly	2019-03-31	46507000.0	+48.0%	USD	10-Q	2020-05-01
Quarterly	2019-09-30	22671000.0	-51.3%	USD	10-Q	2020-10-30
Quarterly	2019-12-31	47771000.0	+110.7%	USD	10-Q	2021-01-29
Quarterly	2020-03-31	77360000.0	+61.9%	USD	10-Q	2021-04-30
Quarterly	2020-09-30	13501000.0	-82.5%	USD	10-Q	2021-10-29
Quarterly	2020-12-31	48443000.0	+258.8%	USD	10-Q	2022-01-28
Quarterly	2021-03-31	74805000.0	+54.4%	USD	10-Q	2022-04-29
Quarterly	2021-09-30	27340000.0	-63.5%	USD	10-Q	2022-10-28
Quarterly	2021-12-31	57747000.0	+111.2%	USD	10-Q	2023-01-27
Quarterly	2022-03-31	106192000.0	+83.9%	USD	10-Q	2023-04-28
Quarterly	2022-09-30	29056000.0	-72.6%	USD	10-Q	2023-10-27
Quarterly	2022-12-31	56406000.0	+94.1%	USD	10-Q	2024-01-25
Quarterly	2023-03-31	85223000.0	+51.1%	USD	10-Q	2024-04-26
Quarterly	2023-09-30	30035000.0	-64.8%	USD	10-Q	2024-10-25
Quarterly	2023-12-31	53388000.0	+77.8%	USD	10-Q	2025-01-31
Quarterly	2024-03-31	74579000.0	+39.7%	USD	10-Q	2025-04-24
Quarterly	2024-09-30	17840000.0	-76.1%	USD	10-Q	2025-10-31
Quarterly	2024-12-31	38484000.0	+115.7%	USD	10-Q	2026-01-30
Quarterly	2025-03-31	59280000.0	+54.0%	USD	10-Q	2025-04-24
Quarterly	2025-09-30	42965000.0	-27.5%	USD	10-Q	2025-10-31
Quarterly	2025-12-31	71504000.0	+66.4%	USD	10-Q	2026-01-30
Annual	2016-06-30	58534000.0	—	USD	10-K	2018-08-17
Annual	2017-06-30	62219000.0	+6.3%	USD	10-K	2019-08-08
Annual	2018-06-30	62581000.0	+0.6%	USD	10-K	2020-08-13
Annual	2019-06-30	68710000.0	+9.8%	USD	10-K	2021-08-17
Annual	2020-06-30	95330000.0	+38.7%	USD	10-K	2022-08-12
Annual	2021-06-30	102712000.0	+7.7%	USD	10-K	2023-08-11
Annual	2022-06-30	134835000.0	+31.3%	USD	10-K	2024-08-09
Annual	2023-06-30	119672000.0	-11.2%	USD	10-K	2025-08-08
Annual	2024-06-30	99460000.0	-16.9%	USD	10-K	2025-08-08
Annual	2025-06-30	89865000.0	-9.6%	USD	10-K	2025-08-08

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	141232000.0	—	shares	10-Q	2017-04-28
Quarterly	2016-09-30	142090000.0	+0.6%	shares	10-Q	2017-10-27
Quarterly	2016-12-31	142097000.0	+0.0%	shares	10-Q	2018-01-24
Quarterly	2017-03-31	142724000.0	+0.4%	shares	10-Q	2018-04-27
Quarterly	2017-09-30	143480000.0	+0.5%	shares	10-Q	2018-10-26
Quarterly	2017-12-31	143855000.0	+0.3%	shares	10-Q	2019-02-01
Quarterly	2018-03-31	143985000.0	+0.1%	shares	10-Q	2019-05-03
Quarterly	2018-09-30	144030000.0	+0.0%	shares	10-Q	2019-10-25
Quarterly	2018-12-31	144349000.0	+0.2%	shares	10-Q	2020-01-31
Quarterly	2019-03-31	144333000.0	-0.0%	shares	10-Q	2020-05-01
Quarterly	2019-09-30	145099000.0	+0.5%	shares	10-Q	2020-10-30
Quarterly	2019-12-31	145575000.0	+0.3%	shares	10-Q	2021-01-29
Quarterly	2020-03-31	145680000.0	+0.1%	shares	10-Q	2021-04-30
Quarterly	2020-09-30	146100000.0	+0.3%	shares	10-Q	2021-10-29
Quarterly	2020-12-31	146421000.0	+0.2%	shares	10-Q	2022-01-28
Quarterly	2021-03-31	145513000.0	-0.6%	shares	10-Q	2022-04-29
Quarterly	2021-09-30	146860000.0	+0.9%	shares	10-Q	2022-10-28
Quarterly	2021-12-31	147040000.0	+0.1%	shares	10-Q	2023-01-27
Quarterly	2022-03-31	146962000.0	-0.1%	shares	10-Q	2023-04-28
Quarterly	2022-09-30	147134000.0	+0.1%	shares	10-Q	2023-10-27
Quarterly	2022-12-31	147405000.0	+0.2%	shares	10-Q	2024-01-25
Quarterly	2023-03-31	147395000.0	-0.0%	shares	10-Q	2024-04-26
Quarterly	2023-09-30	147486000.0	+0.1%	shares	10-Q	2024-10-25
Quarterly	2023-12-31	147545000.0	+0.0%	shares	10-Q	2025-01-31
Quarterly	2024-03-31	147450000.0	-0.1%	shares	10-Q	2025-04-24
Quarterly	2024-09-30	147599000.0	+0.1%	shares	10-Q	2025-10-31
Quarterly	2024-12-31	147481000.0	-0.1%	shares	10-Q	2026-01-30
Quarterly	2025-03-31	147220000.0	-0.2%	shares	10-Q	2025-04-24
Quarterly	2025-09-30	146899000.0	-0.2%	shares	10-Q	2025-10-31
Quarterly	2025-12-31	146372000.0	-0.4%	shares	10-Q	2026-01-30
Annual	2016-06-30	141669000.0	—	shares	10-K	2018-08-17
Annual	2017-06-30	142453000.0	+0.6%	shares	10-K	2019-08-08
Annual	2018-06-30	143987000.0	+1.1%	shares	10-K	2020-08-13
Annual	2019-06-30	144484000.0	+0.3%	shares	10-K	2021-08-17
Annual	2020-06-30	145652000.0	+0.8%	shares	10-K	2022-08-12
Annual	2021-06-30	146451000.0	+0.5%	shares	10-K	2023-08-11
Annual	2022-06-30	147043000.0	+0.4%	shares	10-K	2024-08-09
Annual	2023-06-30	147455000.0	+0.3%	shares	10-K	2025-08-08
Annual	2024-06-30	147550000.0	+0.1%	shares	10-K	2025-08-08
Annual	2025-06-30	147340000.0	-0.1%	shares	10-K	2025-08-08

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

658,392,000

Total Liabilities (latest annual)

2,206,532,000

Current Liabilities (latest annual)

1,019,120,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0543	—	ratio	10-Q	2017-04-28
Quarterly	2016-09-30	0.0429	-20.9%	ratio	10-Q	2017-10-27
Quarterly	2016-12-31	0.0449	+4.5%	ratio	10-Q	2018-01-24
Quarterly	2017-03-31	0.0473	+5.5%	ratio	10-Q	2018-04-27
Quarterly	2017-09-30	0.0420	-11.2%	ratio	10-Q	2019-05-03
Quarterly	2017-12-31	0.0047	-88.8%	ratio	10-Q	2019-05-03
Quarterly	2018-03-31	0.0533	+1029.4%	ratio	10-Q	2019-05-03
Quarterly	2018-09-30	0.0556	+4.4%	ratio	10-Q	2020-05-01
Quarterly	2018-12-31	0.0637	+14.5%	ratio	10-Q	2020-05-01
Quarterly	2019-03-31	0.0522	-18.2%	ratio	10-Q	2020-05-01
Quarterly	2019-09-30	0.0567	+8.8%	ratio	10-Q	2021-04-30
Quarterly	2019-12-31	0.0711	+25.3%	ratio	10-Q	2021-04-30
Quarterly	2020-03-31	0.0723	+1.7%	ratio	10-Q	2021-04-30
Quarterly	2020-09-30	0.0666	-7.9%	ratio	10-Q	2022-04-29
Quarterly	2020-12-31	0.0627	-5.9%	ratio	10-Q	2022-04-29
Quarterly	2021-03-31	-0.0290	-146.2%	ratio	10-Q	2022-04-29
Quarterly	2021-09-30	0.0673	+332.3%	ratio	10-Q	2023-04-28
Quarterly	2021-12-31	0.0641	-4.7%	ratio	10-Q	2023-04-28
Quarterly	2022-03-31	0.0546	-14.9%	ratio	10-Q	2023-04-28
Quarterly	2022-09-30	0.0613	+12.3%	ratio	10-Q	2024-04-26
Quarterly	2022-12-31	0.0602	-1.9%	ratio	10-Q	2024-04-26
Quarterly	2023-03-31	0.0591	-1.7%	ratio	10-Q	2024-04-26
Quarterly	2023-09-30	0.0516	-12.7%	ratio	10-Q	2025-04-24
Quarterly	2023-12-31	0.0466	-9.8%	ratio	10-Q	2025-04-24
Quarterly	2024-03-31	0.0649	+39.3%	ratio	10-Q	2025-04-24
Quarterly	2024-09-30	0.0599	-7.7%	ratio	10-Q	2026-01-30
Quarterly	2024-12-31	0.0656	+9.5%	ratio	10-Q	2026-01-30
Quarterly	2025-03-31	0.0658	+0.3%	ratio	10-Q	2025-04-24
Quarterly	2025-09-30	0.0569	-13.5%	ratio	10-Q	2026-01-30
Quarterly	2025-12-31	0.0621	+9.1%	ratio	10-Q	2026-01-30
Annual	2016-06-30	0.2079	—	ratio	10-K	2018-08-17
Annual	2017-06-30	0.1746	-16.0%	ratio	10-K	2019-08-08
Annual	2018-06-30	0.1533	-12.2%	ratio	10-K	2020-08-13
Annual	2019-06-30	0.1952	+27.4%	ratio	10-K	2021-08-17
Annual	2020-06-30	0.2490	+27.5%	ratio	10-K	2022-08-12
Annual	2021-06-30	0.1644	-34.0%	ratio	10-K	2023-08-11
Annual	2022-06-30	0.2319	+41.0%	ratio	10-K	2024-08-09
Annual	2023-06-30	0.2173	-6.3%	ratio	10-K	2025-08-08
Annual	2024-06-30	0.2099	-3.4%	ratio	10-K	2025-08-08
Annual	2025-06-30	0.2347	+11.8%	ratio	10-K	2025-08-08

8-K Material Event Details

39 filings · 99 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

786 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	4,991	$0.00	$0	34,939
2026-04-07	Farrell Michael J.	Chairman and CEO	Open-market sell S	ResMed Common Stock	4,991	$225.50	$1,125,486	466,223
2026-04-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	4,991	$146.34	$730,383	471,214
2026-04-01	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$224.31	$224,310	83,495
2026-03-09	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	4,991	$0.00	$0	39,930
2026-03-09	Farrell Michael J.	Chairman and CEO	Open-market sell S	ResMed Common Stock	4,991	$251.03	$1,252,902	466,223
2026-03-09	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	4,991	$146.34	$730,383	471,214
2026-03-04	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$260.22	$520,440	62,773
2026-03-02	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$254.30	$254,300	84,495
2026-02-09	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	4,991	$0.00	$0	44,921
2026-02-09	Farrell Michael J.	Chairman and CEO	Open-market sell S	ResMed Common Stock	4,991	$273.78	$1,366,436	466,223
2026-02-09	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	4,991	$146.34	$730,383	471,214
2026-02-04	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$251.31	$502,620	64,773
2026-02-02	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$257.03	$257,030	85,495
2026-01-07	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$248.83	$497,660	66,773
2026-01-02	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$241.75	$241,750	86,495
2025-12-08	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	4,991	$0.00	$0	54,903
2025-12-08	Farrell Michael J.	Chairman and CEO	Open-market sell S	ResMed Common Stock	4,991	$251.41	$1,254,796	466,223
2025-12-08	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	4,991	$146.34	$730,383	471,214
2025-12-03	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$251.47	$502,940	68,773
2025-12-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	50	$244.16	$12,208	9,791
2025-11-25	De Witte Jan	Dir	Open-market sell S	ReMed Common Stock	2,055	$255.00	$524,025	4,261
2025-11-24	Farrell Michael J.	Chairman and CEO	Equity grant / award A · derivative	ResMed Common Stock Options	33,288	$250.52	$8,339,310	33,288
2025-11-20	Leong Justin	Chief Product Officer	Equity grant / award A	ReMed Common Stock	1,848	$0.00	$0	29,028
2025-11-14	FARRELL PETER C	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	11,442	$0.00	$0	0
2025-11-14	FARRELL PETER C	Dir	Other disposed transaction F	ResMed Common Stock	7,314	$244.46	$1,787,980	70,238
2025-11-14	FARRELL PETER C	Dir	Exercise / conversion M	ResMed Common Stock	11,442	$101.64	$1,162,965	77,552
2025-11-11	Gill Harjit	Dir	Other disposed transaction F	ResMed Common Stock	38	$250.10	$9,556	9,867
2025-11-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	7,028	$0.00	$0	0
2025-11-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M · derivative	ResMed Common Stock Options	983	$0.00	$0	7,028
2025-11-07	Farrell Michael J.	Chairman and CEO	Open-market sell S	ResMed Common Stock	8,011	$249.75	$2,000,773	467,866
2025-11-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	7,028	$101.64	$714,326	475,877
2025-11-07	Farrell Michael J.	Chairman and CEO	Exercise / conversion M	ResMed Common Stock	983	$101.64	$99,912	468,849
2025-11-03	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,000	$0.00	$0	0
2025-11-03	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$247.54	$742,620	85,745
2025-11-03	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,000	$101.64	$203,280	88,745
2025-10-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	8,011
2025-10-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$282.85	$2,265,332	467,792
2025-10-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	475,801
2025-10-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,000	$0.00	$0	2,000
2025-10-01	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$274.36	$823,080	86,745
2025-10-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,000	$101.64	$203,280	89,745
2025-09-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	16,020
2025-09-08	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$278.14	$2,227,590	467,792
2025-09-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	475,801
2025-09-02	Mowad-Nassar Nicole	Dir	Equity grant / award A	ResMed Common Stock	241	$0.00	$0	241
2025-08-18	Hernandez John	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	2,575	$0.00	$0	0
2025-08-18	Hernandez John	Dir	Open-market sell S	ResMed Common Stock	2,575	$287.10	$739,289	4,045
2025-08-18	Hernandez John	Dir	Exercise / conversion M	ResMed Common Stock	2,575	$148.90	$383,418	6,620
2025-08-15	Leong Justin	Chief Product Officer	Equity grant / award A	ReMed Common Stock	5,462	$0.00	$0	27,180
2025-08-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	24,029
2025-08-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$279.48	$2,238,379	455,503
2025-08-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,512
2025-08-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,000	$0.00	$0	6,000
2025-08-01	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$281.90	$845,700	83,283
2025-08-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,000	$101.64	$203,280	86,283
2025-07-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	32,038
2025-07-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$256.72	$2,056,076	455,503
2025-07-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,512
2025-07-02	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	945	$255.49	$241,438	68,273
2025-07-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	917	$0.00	$0	8,000
2025-07-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,966	$0.00	$0	8,917
2025-07-01	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,883	$256.99	$997,892	84,283
2025-07-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	917	$101.64	$93,204	88,166
2025-07-01	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	1,966	$101.64	$199,824	87,249
2025-06-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	40,047
2025-06-09	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$251.21	$2,011,910	455,503
2025-06-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,512
2025-06-04	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$247.32	$494,640	69,218
2025-06-02	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$243.78	$243,780	85,283
2025-05-22	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,644	$244.59	$891,286	86,283
2025-05-20	De Witte Jan	Dir	Open-market sell S	ReMed Common Stock	2,000	$243.47	$486,940	5,806
2025-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	48,056
2025-05-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$243.23	$1,948,003	455,503
2025-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,512
2025-04-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$215.58	$215,580	89,864
2025-04-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	56,065
2025-04-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$209.85	$1,680,699	455,472
2025-04-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,482
2025-04-02	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$219.74	$439,480	73,218
2025-04-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	64	$222.86	$14,263	8,846
2025-03-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$230.36	$230,360	90,864
2025-03-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	64,074
2025-03-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$229.20	$1,835,692	455,472
2025-03-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,481
2025-03-05	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$227.71	$455,420	75,218
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	4,726	$0.00	$0	5,882
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	514	$0.00	$0	169
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	3,506	$0.00	$0	3,589
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	367	$0.00	$0	105
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	4,726	$235.43	$1,112,624	9,725
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	514	$235.25	$120,918	14,451
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	3,506	$235.40	$825,308	14,965
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	367	$235.25	$86,336	18,471
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	4,726	$211.76	$1,000,778	18,838
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	514	$146.34	$75,219	14,112
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	3,506	$146.34	$513,068	13,598
2025-03-03	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	367	$211.76	$77,716	10,092
2025-02-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$238.98	$238,980	91,864
2025-02-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	8,009	$0.00	$0	72,083
2025-02-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	8,009	$236.77	$1,896,307	455,472
2025-02-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	8,009	$101.64	$814,035	463,481
2025-02-05	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$242.11	$484,220	77,218
2025-02-03	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	64	$242.42	$15,515	8,974
2025-01-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$234.04	$234,040	92,864
2025-01-02	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$230.99	$461,980	79,218
2024-12-09	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$244.23	$244,230	93,864
2024-12-04	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$245.65	$491,300	81,218
2024-12-02	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	74	$248.91	$18,419	9,113
2024-11-29	Rider Michael J	Global General Counsel	Equity grant / award G	ResMed Common Stock	173	$0.00	$0	9,187
2024-11-27	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	2,000	$249.66	$499,330	0
2024-11-27	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	2,000	$0.00	$0	2,000
2024-11-25	Farrell Michael J.	Chief Executive Officer	Equity grant / award A · derivative	ResMed Common Stock Options	33,036	$249.56	$8,244,464	33,036
2024-11-22	Leong Justin	Chief Product Officer	Open-market sell S	ReMed Common Stock	6,160	$243.09	$1,497,416	21,718
2024-11-20	TAYLOR RONALD R	Dir	Equity grant / award A	ResMed Common Stock	1,083	$0.00	$0	23,698
2024-11-12	De Witte Jan	Dir	Open-market sell S	ReMed Common Stock	796	$248.81	$198,053	6,723
2024-11-11	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	3,453	$252.38	$871,443	455,472
2024-11-11	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	2,227	$252.38	$562,016	458,925
2024-11-11	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	3,101	$252.38	$782,725	461,152
2024-11-11	FARRELL PETER C	Dir	Other disposed transaction F	ResMed Common Stock	528	$252.38	$133,233	82,676
2024-11-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$249.00	$249,000	94,864
2024-11-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	14,683	$0.00	$0	0
2024-11-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$246.26	$3,615,821	464,254
2024-11-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	14,683	$84.98	$1,247,761	478,937
2024-11-06	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$248.74	$497,480	83,204
2024-11-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	69	$242.00	$16,698	10,443
2024-10-30	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Other acquired transaction J	ResMed Common Stock	9,628	$0.00	$0	9,628
2024-10-30	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Other disposed transaction J	ResMed Common Stock	9,628	$0.00	$0	12,160
2024-10-11	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	4,260	$0.00	$0	0
2024-10-11	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	4,260	$238.48	$1,015,925	21,788
2024-10-11	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	4,260	$101.64	$432,986	26,048
2024-10-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$233.47	$233,470	95,812
2024-10-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	14,683	$0.00	$0	14,683
2024-10-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$231.91	$3,405,206	464,169
2024-10-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	14,683	$84.98	$1,247,761	478,852
2024-10-02	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$237.20	$474,400	85,204
2024-09-12	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M · derivative	ResMed Common Stock Options	5,000	$0.00	$0	4,260
2024-09-12	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Open-market sell S	ResMed Common Stock	5,000	$252.56	$1,262,800	21,788
2024-09-12	Ghoshal Kaushik	Chief Commercial Officer, SaaS	Exercise / conversion M	ResMed Common Stock	5,000	$101.64	$508,200	26,788
2024-09-09	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$246.42	$246,420	96,812
2024-09-04	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	2,000	$239.90	$479,800	87,204
2024-09-03	DelOrefice Christopher	Dir	Equity grant / award A	ResMed Common Stock	267	$0.00	$0	267
2024-08-20	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	882	$231.00	$203,742	10,512
2024-08-15	Sandercock Brett	Chief Financial Officer	Equity grant / award A	ResMed Common Stock	841	$0.00	$0	97,812
2024-08-15	Sandercock Brett	Chief Financial Officer	Equity grant / award A	ResMed Common Stock	7,915	$0.00	$0	96,971
2024-08-15	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	4,098	$0.00	$0	464,169
2024-08-15	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	19,272	$0.00	$0	460,071
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M · derivative	ResMed Common Stock Options	1,037	$0.00	$0	9,260
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M · derivative	ResMed Common Stock Options	6,877	$0.00	$0	0
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M · derivative	ResMed Common Stock Options	2,086	$0.00	$0	0
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Open-market sell S	ResMed Common Stock	10,000	$216.60	$2,166,000	13,032
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M	ResMed Common Stock	1,037	$101.64	$105,401	23,032
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M	ResMed Common Stock	6,877	$95.80	$658,817	21,995
2024-08-12	Ghoshal Kaushik	President, SaaS Business	Exercise / conversion M	ResMed Common Stock	2,086	$95.80	$199,839	15,118
2024-08-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$212.16	$212,160	89,056
2024-08-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	14,683	$0.00	$0	44,049
2024-08-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$214.25	$3,145,905	440,799
2024-08-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	14,683	$84.98	$1,247,761	455,482
2024-08-05	Leong Justin	President, Asia Latin America	Open-market sell S	ReMed Common Stock	48,000	$217.07	$10,419,552	18,741
2024-07-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	14,683	$0.00	$0	58,732
2024-07-08	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$192.97	$2,833,330	440,799
2024-07-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	14,683	$84.98	$1,247,761	455,482
2024-06-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	1,000	$209.81	$209,810	91,056
2024-06-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	14,683	$0.00	$0	73,415
2024-06-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$211.66	$3,107,739	440,799
2024-06-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	14,683	$84.98	$1,247,761	455,482
2024-06-04	Rider Michael J	Global General Counsel	Other disposed transaction F	ResMed Common Stock	267	$206.33	$55,140	6,444
2024-05-24	Burt Carol	Dir	Equity grant / award G	ResMed Common Stock	47	$0.00	$0	14,892
2024-05-15	FARRELL PETER C	Dir	Equity grant / award G	ResMed Common Stock	68,200	$0.00	$0	89,204
2024-05-15	De Witte Jan	Dir	Open-market sell S	ReMed Common Stock	360	$218.29	$78,584	7,519
2024-05-08	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	12,000	$0.00	$0	10,883
2024-05-08	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	13,000	$211.37	$2,747,810	92,056
2024-05-08	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	12,000	$101.64	$1,219,680	105,056
2024-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	13,507	$0.00	$0	88,098
2024-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,176	$0.00	$0	101,605
2024-05-07	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	14,683	$216.50	$3,178,815	440,752
2024-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	13,507	$84.98	$1,147,825	455,435
2024-05-07	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	1,176	$84.98	$99,936	441,928
2024-04-29	Burt Carol	Dir	Equity grant / award G	ResMed Common Stock	234	$0.00	$0	14,939
2024-03-04	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	81	$180.00	$14,580	6,607
2024-03-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	200	$173.25	$34,650	6,688
2024-02-22	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	10,935	$182.66	$1,997,434	157,404
2023-11-27	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$152.62	$457,860	92,962
2023-11-22	Rider Michael J	Global General Counsel	Equity grant / award G	ResMed Common Stock	72	$0.00	$0	6,888
2023-11-20	Douglas Robert Andrew	President and COO	Other disposed transaction F	ResMed Common Stock	1,375	$148.94	$204,825	13,849
2023-11-16	SULPIZIO RICHARD	Dir	Equity grant / award A	ResMed Common Stock	1,768	$0.00	$0	16,713
2023-11-16	Burt Carol	Dir	Equity grant / award A	ResMed Common Stock	1,768	$0.00	$0	2,890
2023-11-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,678	$0.00	$0	3,462
2023-11-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,678	$152.04	$863,281	440,986
2023-11-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,678	$57.76	$327,961	446,664
2023-11-13	Rider Michael J	Global General Counsel	Other disposed transaction F	ResMed Common Stock	93	$143.60	$13,408	6,960
2023-11-13	Rider Michael J	Global General Counsel	Other disposed transaction F	ResMed Common Stock	137	$143.60	$19,615	7,054
2023-11-13	Rider Michael J	Global General Counsel	Other disposed transaction F	ResMed Common Stock	118	$143.60	$16,883	7,190
2023-11-13	Rider Michael J	Global General Counsel	Other disposed transaction F	ResMed Common Stock	92	$143.60	$13,159	7,308
2023-11-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	25	$143.42	$3,586	7,358
2023-10-16	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	9,140
2023-10-16	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$140.70	$798,464	449,360
2023-10-16	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	455,035
2023-10-02	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	25	$145.92	$3,648	7,383
2023-09-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	14,815
2023-09-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$146.35	$830,514	449,360
2023-09-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	455,035
2023-09-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	25	$161.15	$4,029	7,408
2023-08-25	BLAISE LUCILE	President, Sleep & RC Business	Other disposed transaction F	ResMed Common Stock	380	$165.67	$62,903	10,355
2023-08-17	Rider Michael J	Global General Counsel	Equity grant / award A	ResMed Common Stock	2,247	$0.00	$0	7,433
2023-08-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	20,490
2023-08-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$183.20	$1,039,647	436,930
2023-08-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	442,605
2023-08-01	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	25	$224.12	$5,603	5,186
2023-07-17	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	26,165
2023-07-17	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$221.27	$1,255,686	436,930
2023-07-17	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	442,605
2023-07-13	Ghoshal Kaushik	President, SaaS Business	Open-market sell S	ResMed Common Stock	500	$220.00	$110,000	11,787
2023-07-03	Rider Michael J	Global General Counsel	Open-market sell S	ResMed Common Stock	25	$217.21	$5,430	5,211
2023-06-15	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	1,500	$216.27	$324,405	253,526
2023-06-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$219.79	$329,685	89,729
2023-06-02	Ghoshal Kaushik	President, SaaS Business	Open-market sell S	ResMed Common Stock	500	$220.00	$110,000	12,287
2023-05-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	37,515
2023-05-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$232.10	$1,317,191	436,930
2023-05-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	442,605
2023-05-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	12,574	$233.13	$2,931,395	90,942
2023-05-09	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,426	$232.05	$795,000	103,516
2023-05-03	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	12,600	$237.17	$2,988,375	166,896
2023-05-01	Ghoshal Kaushik	President, SaaS Business	Open-market sell S	ResMed Common Stock	500	$239.30	$119,650	12,704
2023-04-24	Ghoshal Kaushik	President, SaaS Business	Open-market sell S	ResMed Common Stock	2,000	$230.00	$460,000	13,204
2023-04-17	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	1,500	$224.65	$336,975	256,526
2023-04-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$218.23	$327,345	92,672
2023-03-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	48,865
2023-03-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$206.95	$1,174,451	436,900
2023-03-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	442,575
2023-03-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$216.69	$325,035	94,172
2023-02-17	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	10,000	$215.22	$2,152,196	106,880
2023-02-15	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	1,500	$213.50	$320,250	261,445
2023-02-13	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	4,000	$215.00	$860,000	116,880
2023-02-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$224.50	$336,750	95,672
2023-02-02	Drexler Karen	Dir	Open-market sell S	ResMed Common Stock	594	$226.58	$134,589	7,987
2023-01-17	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	1,500	$220.43	$330,645	226,208
2023-01-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$210.07	$315,105	97,172
2022-12-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	65,890
2022-12-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$215.63	$1,223,727	436,900
2022-12-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	442,575
2022-12-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,500	$229.81	$344,715	98,672
2022-11-28	PENDARVIS DAVID	Chief Administrative Officer	Equity grant / award G	ResMed Common Stock	7,300	$0.00	$0	100,172
2022-11-25	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	683	$0.00	$0	12,540
2022-11-25	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	683	$146.34	$99,950	107,472
2022-11-23	Leong Justin	President, Asia Latin America	Equity grant / award A	ReMed Common Stock	6,924	$0.00	$0	66,741
2022-11-23	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	33,239	$224.40	$7,458,832	436,900
2022-11-23	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	56,115	$0.00	$0	470,139
2022-11-22	Leong Justin	President, Asia Latin America	Exercise / conversion M · derivative	ResMed Common Stock Options	15,000	$0.00	$0	0
2022-11-22	Leong Justin	President, Asia Latin America	Open-market sell S	ReMed Common Stock	3,777	$229.50	$866,820	59,817
2022-11-22	Leong Justin	President, Asia Latin America	Exercise / conversion M	ReMed Common Stock	15,000	$57.76	$866,400	63,594
2022-11-21	BLAISE LUCILE	President, Sleep & RC Business	Other disposed transaction F	ResMed Common Stock	75	$224.40	$16,830	6,552
2022-11-21	BLAISE LUCILE	President, Sleep & RC Business	Other disposed transaction F	ResMed Common Stock	78	$224.40	$17,503	6,627
2022-11-21	BLAISE LUCILE	President, Sleep & RC Business	Other disposed transaction F	ResMed Common Stock	114	$224.40	$25,582	6,705
2022-11-16	De Witte Jan	Dir	Equity grant / award A	ReMed Common Stock	1,122	$0.00	$0	6,111
2022-11-16	BLAISE LUCILE	President, Sleep & RC Business	Equity grant / award A · derivative	ResMed Common Stock Options	2,410	$224.58	$541,238	2,410
2022-11-16	SULPIZIO RICHARD	Dir	Equity grant / award A	ResMed Common Stock	1,122	$0.00	$0	14,945
2022-11-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	71,565
2022-11-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$224.64	$1,274,837	414,024
2022-11-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	419,699
2022-11-15	BLAISE LUCILE	President, Sleep & RC Business	Other disposed transaction F	ResMed Common Stock	169	$225.18	$38,055	6,819
2022-11-11	Ghoshal Kaushik	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	591	$225.18	$133,081	13,734
2022-11-11	Ghoshal Kaushik	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	307	$225.18	$69,130	14,325
2022-11-10	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	4,880	$220.83	$1,077,650	0
2022-11-10	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	1,000	$0.00	$0	4,880
2022-11-07	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	4,000	$212.02	$848,068	106,303
2022-11-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$215.23	$332,530	102,334
2022-10-31	FARRELL PETER C	Dir	Equity grant / award G	ResMed Common Stock	4,550	$0.00	$0	178,502
2022-10-31	FARRELL PETER C	Dir	Open-market sell S	ResMed Common Stock	9,050	$221.98	$2,008,877	183,052
2022-10-17	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	77,240
2022-10-17	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$214.58	$1,217,723	422,570
2022-10-17	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	428,245
2022-10-14	Douglas Robert Andrew	President and COO	Exercise / conversion M · derivative	ResMed Common Stock Options	16,888	$0.00	$0	18,032
2022-10-14	Douglas Robert Andrew	President and COO	Exercise / conversion M · derivative	ResMed Common Stock Options	1,145	$0.00	$0	34,920
2022-10-14	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	11,355	$215.09	$2,442,298	35,086
2022-10-14	Douglas Robert Andrew	President and COO	Exercise / conversion M	ResMed Common Stock	16,888	$58.24	$983,557	46,441
2022-10-14	Douglas Robert Andrew	President and COO	Exercise / conversion M	ResMed Common Stock	1,145	$58.24	$66,685	29,553
2022-10-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$220.19	$340,194	103,879
2022-09-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	82,915
2022-09-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$228.96	$1,299,336	422,570
2022-09-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	428,245
2022-09-06	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$216.92	$335,141	105,424
2022-08-18	Ghoshal Kaushik	President, SaaS Business	Equity grant / award A	ResMed Common Stock	3,366	$0.00	$0	14,628
2022-08-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	88,590
2022-08-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$238.09	$1,351,166	405,260
2022-08-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,935
2022-08-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	0
2022-08-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$240.66	$601,650	106,426
2022-08-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,926
2022-08-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$240.72	$371,912	105,286
2022-07-22	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	2,500
2022-07-22	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	7,500	$235.00	$1,762,500	106,426
2022-07-22	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	113,926
2022-07-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	94,265
2022-07-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$224.94	$1,276,517	405,260
2022-07-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,935
2022-07-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$212.33	$328,050	106,831
2022-06-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	99,940
2022-06-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$202.54	$1,149,410	405,260
2022-06-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,935
2022-06-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$209.44	$323,585	108,376
2022-05-16	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	105,615
2022-05-16	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$196.61	$1,115,745	405,260
2022-05-16	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,935
2022-05-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,545	$200.00	$309,000	109,858
2022-04-18	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	111,290
2022-04-18	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$232.41	$1,318,947	405,229
2022-04-18	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,904
2022-04-11	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	10,000
2022-04-11	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$247.00	$617,500	106,354
2022-04-11	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,854
2022-04-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,544	$246.60	$380,750	111,403
2022-03-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	116,965
2022-03-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$242.37	$1,375,422	405,229
2022-03-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,904
2022-03-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	12,500
2022-03-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$241.29	$603,225	106,354
2022-03-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,854
2022-03-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,544	$250.62	$386,957	112,947
2022-02-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,675	$0.00	$0	122,640
2022-02-15	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,675	$234.06	$1,328,271	405,229
2022-02-15	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	5,675	$57.76	$327,788	410,904
2022-02-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	15,000
2022-02-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$241.86	$604,650	106,354
2022-02-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,854
2022-02-03	PENDARVIS DAVID	Chief Administration Officer	Open-market sell S	ResMed Common Stock	1,544	$232.87	$359,551	114,491
2022-01-18	Douglas Robert Andrew	President and COO	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	78,098
2022-01-18	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	8,000	$247.80	$1,982,400	17,175
2022-01-18	Douglas Robert Andrew	President and COO	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	25,175
2022-01-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	17,500
2022-01-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$235.00	$587,500	106,354
2022-01-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,854
2022-01-03	PENDARVIS DAVID	Chief Administration Officer	Open-market sell S	ResMed Common Stock	1,544	$258.52	$399,155	116,035
2021-12-31	Leong Justin	President, Asia Latin America	Other disposed transaction F	ReMed Common Stock	562	$259.47	$145,822	49,295
2021-12-15	Douglas Robert Andrew	President and COO	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	86,098
2021-12-15	Douglas Robert Andrew	President and COO	Open-market sell S	ResMed Common Stock	8,000	$256.52	$2,052,160	17,175
2021-12-15	Douglas Robert Andrew	President and COO	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	25,175
2021-12-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	20,000
2021-12-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$264.92	$662,300	106,354
2021-12-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	108,854
2021-12-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,544	$257.93	$398,244	117,579
2021-12-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$256.84	$616,416	76,721
2021-11-30	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	3,880	$0.00	$0	3,880
2021-11-30	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	3,880	$0.00	$0	5,090
2021-11-24	Leong Justin	President, Asia Latin America	Other disposed transaction F	ReMed Common Stock	1,339	$254.81	$341,191	48,391
2021-11-23	Douglas Robert Andrew	President and COO ResMed Inc.	Equity grant / award G	ResMed Common Stock	791	$0.00	$0	234,995
2021-11-22	Burt Carol	Dir	Open-market sell S	ResMed Common Stock	1,500	$260.00	$390,000	13,095
2021-11-19	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	44,250	$0.00	$0	405,229
2021-11-18	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	4,469	$0.00	$0	449,479
2021-11-18	Leong Justin	President, Asia Latin America	Equity grant / award A	ReMed Common Stock	638	$0.00	$0	49,933
2021-11-18	Burt Carol	Dir	Equity grant / award A	ResMed Common Stock	956	$0.00	$0	15,551
2021-11-18	Drexler Karen	Dir	Equity grant / award A · derivative	ResMed Common Stock Options	1,695	$0.00	$0	1,695
2021-11-18	Drexler Karen	Dir	Equity grant / award A	ResMed Common Stock	478	$0.00	$0	7,459
2021-11-17	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	42,210	$254.81	$10,755,530	445,010
2021-11-16	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	71,262	$254.81	$18,158,270	487,220
2021-11-16	Leong Justin	President, Asia Latin America	Equity grant / award A	ReMed Common Stock	9,162	$254.81	$2,334,569	49,857
2021-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	94,098
2021-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$271.75	$2,174,000	21,266
2021-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	29,266
2021-11-15	Burt Carol	Dir	Open-market sell S	ResMed Common Stock	1,187	$270.80	$321,440	0
2021-11-11	Douglas Robert Andrew	President and COO ResMed Inc.	Other disposed transaction F	ResMed Common Stock	945	$259.47	$245,199	21,266
2021-11-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	22,500
2021-11-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$260.58	$651,450	84,833
2021-11-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	87,333
2021-11-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,485	$264.29	$392,471	120,987
2021-11-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$264.35	$634,430	73,177
2021-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	102,098
2021-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$255.77	$2,046,160	22,149
2021-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	30,149
2021-10-11	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	25,000
2021-10-11	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	5,000	$253.37	$1,266,850	84,786
2021-10-11	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	89,786
2021-10-08	Hollingshead James	President, Sleep Business	Other disposed transaction F	ResMed Common Stock	234	$246.52	$57,686	75,577
2021-10-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$260.79	$387,795	122,472
2021-10-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$261.33	$627,183	74,479
2021-09-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	110,098
2021-09-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$291.83	$2,334,640	22,149
2021-09-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	30,149
2021-09-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,500	$0.00	$0	27,500
2021-09-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	5,000	$297.33	$1,486,650	87,286
2021-09-10	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	2,500	$57.76	$144,400	92,286
2021-09-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$292.16	$434,442	123,959
2021-09-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$288.41	$432,615	26,731
2021-08-30	Burt Carol	Dir	Equity grant / award G	ResMed Common Stock	347	$0.00	$0	14,595
2021-08-20	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,543	$0.00	$0	30,000
2021-08-20	Sandercock Brett	Chief Financial Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,193	$0.00	$0	35,543
2021-08-20	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	10,736	$281.73	$3,024,653	89,786
2021-08-20	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	5,543	$57.76	$320,164	100,522
2021-08-20	Sandercock Brett	Chief Financial Officer	Exercise / conversion M	ResMed Common Stock	5,193	$57.76	$299,948	94,979
2021-08-19	Hollingshead James	President, Sleep Business	Equity grant / award A	ResMed Common Stock	1,332	$0.00	$0	80,611
2021-08-19	Hollingshead James	President, Sleep Business	Equity grant / award A	ResMed Common Stock	5,741	$0.00	$0	79,279
2021-08-16	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	118,098
2021-08-16	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$275.57	$2,204,560	16,767
2021-08-16	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	24,767
2021-08-13	FARRELL PETER C	Dir	Equity grant / award G	ResMed Common Stock	36,670	$0.00	$0	191,966
2021-08-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$278.05	$695,125	85,002
2021-08-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$269.38	$400,568	123,413
2021-08-02	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$269.00	$403,500	24,165
2021-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	126,098
2021-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$248.00	$1,984,000	16,767
2021-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	24,767
2021-07-12	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$248.46	$621,150	87,502
2021-07-06	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$247.12	$367,467	124,900
2021-07-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$247.30	$593,513	75,938
2021-06-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	134,098
2021-06-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$232.10	$1,856,800	16,767
2021-06-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	24,767
2021-06-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$212.84	$532,100	90,002
2021-06-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$207.00	$307,809	126,387
2021-06-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$206.03	$494,475	78,338
2021-05-21	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$202.01	$484,824	80,738
2021-05-17	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	8,000	$0.00	$0	142,098
2021-05-17	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	8,000	$58.24	$465,920	16,767
2021-05-17	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	8,000	$195.00	$1,560,000	8,766
2021-05-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$196.00	$490,000	92,502
2021-05-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$190.50	$283,274	127,807
2021-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	964	$207.45	$199,982	210,407
2021-04-12	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	4,800	$200.00	$960,000	83,046
2021-04-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$196.15	$291,675	129,294
2021-04-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$194.14	$291,210	30,088
2021-03-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,081	$185.48	$200,504	211,371
2021-03-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$185.00	$462,500	97,422
2021-03-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$191.80	$285,207	130,781
2021-03-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$194.34	$291,510	31,588
2021-02-19	TAYLOR RONALD R	Dir	Open-market sell S	ResMed Common Stock	4,000	$200.14	$800,564	18,769
2021-02-16	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	998	$200.46	$200,059	212,452
2021-02-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$201.37	$503,425	99,922
2021-02-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$204.42	$303,973	132,268
2021-02-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$200.18	$480,437	87,846
2021-01-18	Leong Justin	President, Asia Latin America	Equity grant / award A	ReMed Common Stock	865	$0.00	$0	38,064
2021-01-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	938	$212.86	$199,663	213,450
2021-01-11	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$218.70	$546,750	100,600
2021-01-04	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$211.09	$506,614	88,333
2020-12-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	970	$207.80	$201,566	214,388
2020-12-10	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$211.06	$527,650	103,100
2020-12-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	1,487	$208.36	$309,831	133,694
2020-12-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$210.46	$315,690	34,175
2020-11-27	Gill Harjit	Dir	Other disposed transaction F	ResMed Common Stock	116	$212.11	$24,605	5,229
2020-11-24	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	5,000	$211.00	$1,055,000	105,600
2020-11-23	PENDARVIS DAVID	Chief Administrative Officer	Equity grant / award G	ResMed Common Stock	10,000	$0.00	$0	135,181
2020-11-20	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,176	$0.00	$0	24,519
2020-11-20	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	1,176	$84.98	$99,936	145,181
2020-11-19	TAYLOR RONALD R	Dir	Equity grant / award A	ResMed Common Stock	1,187	$0.00	$0	22,769
2020-11-19	Douglas Robert Andrew	President and COO ResMed Inc.	Equity grant / award A · derivative	ResMed Common Stock Options	20,776	$0.00	$0	20,776
2020-11-17	Leong Justin	President, Asia Latin America	Equity grant / award A	ReMed Common Stock	11,813	$214.74	$2,536,724	37,199
2020-11-11	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	1,211	$212.11	$256,865	27,551
2020-11-11	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	1,418	$212.11	$300,772	28,762
2020-11-11	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	982	$212.11	$208,292	30,180
2020-11-05	Leong Justin	President, Asia Latin America	Exercise / conversion M · derivative	ResMed Common Stock Options	7,740	$0.00	$0	15,000
2020-11-05	Leong Justin	President, Asia Latin America	Open-market sell S	ReMed Common Stock	7,740	$211.36	$1,635,926	25,386
2020-11-05	Leong Justin	President, Asia Latin America	Exercise / conversion M	ReMed Common Stock	7,740	$57.76	$447,062	33,126
2020-11-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,918	$0.00	$0	0
2020-11-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,918	$201.14	$1,190,364	136,128
2020-11-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,918	$57.76	$341,824	142,046
2020-11-02	Burt Carol	Dir	Equity grant / award G	ResMed Common Stock	263	$0.00	$0	13,215
2020-10-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$176.72	$441,800	84,275
2020-10-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,919	$0.00	$0	5,918
2020-10-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,919	$170.07	$1,006,621	136,128
2020-10-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,919	$57.76	$341,881	142,047
2020-10-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$172.84	$259,260	32,589
2020-09-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$175.49	$438,725	86,775
2020-09-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,919	$0.00	$0	11,837
2020-09-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,919	$177.52	$1,050,714	136,128
2020-09-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,919	$57.76	$341,881	142,047
2020-09-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$202.02	$484,854	92,402
2020-08-17	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$177.55	$443,875	89,275
2020-08-13	McHale Richard	President, RC Business	Equity grant / award A	ResMed Common Stock	5,235	$0.00	$0	22,982
2020-08-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,919	$0.00	$0	17,756
2020-08-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,919	$201.99	$1,195,593	133,162
2020-08-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,919	$57.76	$341,881	139,081
2020-07-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$196.98	$492,450	84,796
2020-07-06	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,919	$0.00	$0	23,675
2020-07-06	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,919	$194.64	$1,152,090	133,942
2020-07-06	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,919	$57.76	$341,881	139,861
2020-07-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	2,400	$189.63	$455,112	89,874
2020-06-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,245	$158.79	$197,694	186,743
2020-06-04	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	3,483	$160.82	$560,136	133,942
2020-06-04	PENDARVIS DAVID	Chief Administrative Officer	Equity grant / award A	ResMed Common Stock	7,022	$160.82	$1,129,278	137,425
2020-06-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	5,919	$0.00	$0	29,594
2020-06-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	5,919	$160.61	$950,660	130,403
2020-06-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	5,919	$57.76	$341,881	136,322
2020-06-01	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	239	$161.12	$38,508	130,403
2020-05-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,228	$162.05	$198,997	187,988
2020-05-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,737	$0.00	$0	0
2020-05-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,737	$155.06	$734,515	130,642
2020-05-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,737	$58.24	$275,883	135,379
2020-05-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$164.00	$246,000	32,670
2020-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,222	$159.03	$194,335	189,216
2020-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,739	$0.00	$0	4,737
2020-04-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,739	$152.63	$723,303	130,564
2020-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,739	$58.24	$275,999	135,303
2020-04-02	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	1,200	$150.00	$180,000	94,565
2020-04-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,500	$140.73	$211,095	34,170
2020-03-16	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$137.49	$343,725	94,711
2020-03-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,739	$0.00	$0	9,476
2020-03-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,739	$166.65	$789,757	130,564
2020-03-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,739	$58.24	$275,999	135,303
2020-03-02	Burt Carol	Dir	Open-market sell S	ResMed Common Stock	10,000	$164.90	$1,648,954	13,478
2020-02-20	Hollingshead James	President, Sleep Business	Other disposed transaction F	ResMed Common Stock	9,105	$176.00	$1,602,480	96,965
2020-02-20	Hollingshead James	President, Sleep Business	Equity grant / award A	ResMed Common Stock	15,370	$176.00	$2,705,120	106,070
2020-02-18	Hollingshead James	President, Sleep Business	Other disposed transaction F	ResMed Common Stock	1,274	$174.80	$222,695	90,700
2020-02-10	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	3,000	$172.63	$517,904	17,670
2020-02-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,739	$0.00	$0	14,215
2020-02-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,739	$162.37	$769,469	130,564
2020-02-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,739	$58.24	$275,999	135,303
2020-01-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$158.43	$396,075	99,711
2020-01-13	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	6,647
2020-01-13	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$157.43	$1,047,054	354,700
2020-01-13	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	361,351
2020-01-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,739	$0.00	$0	18,954
2020-01-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,739	$155.25	$735,730	130,564
2020-01-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,739	$58.24	$275,999	135,303
2020-01-02	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	1,200	$155.40	$186,480	93,174
2019-12-16	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,302	$154.71	$201,432	152,044
2019-12-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	13,298
2019-12-09	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$149.64	$995,282	354,700
2019-12-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	361,351
2019-12-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,739	$0.00	$0	23,693
2019-12-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,739	$148.94	$705,827	130,564
2019-12-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,739	$58.24	$275,999	134,943
2019-12-02	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	0
2019-12-02	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$149.89	$119,912	94,374
2019-12-02	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	95,974
2019-11-27	Gill Harjit	Dir	Other disposed transaction F	ResMed Common Stock	102	$143.88	$14,676	4,158
2019-11-26	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	1,370	$149.26	$204,489	0
2019-11-26	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,500	$147.00	$367,500	104,711
2019-11-25	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	1,370	$0.00	$0	1,370
2019-11-25	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	1,370	$0.00	$0	8,970
2019-11-21	Drexler Karen	Dir	Equity grant / award A · derivative	ResMed Common Stock Options	3,889	$0.00	$0	3,889
2019-11-21	Drexler Karen	Dir	Equity grant / award A	ResMed Common Stock	863	$0.00	$0	6,387
2019-11-18	Douglas Robert Andrew	President and COO ResMed Inc.	Equity grant / award G	ResMed Common Stock	680	$0.00	$0	153,346
2019-11-18	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,360	$146.70	$199,512	154,026
2019-11-15	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	20,038	$0.00	$0	800
2019-11-15	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	1,717	$0.00	$0	20,838
2019-11-15	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	20,038	$146.35	$2,932,561	82,349
2019-11-15	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	20,038	$58.24	$1,167,013	102,387
2019-11-15	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	1,717	$58.24	$99,998	82,349
2019-11-11	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,731	$0.00	$0	35,513
2019-11-11	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	1,199	$143.88	$172,512	116,654
2019-11-11	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	727	$143.88	$104,601	117,853
2019-11-11	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	860	$143.88	$123,737	118,580
2019-11-11	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	1,731	$57.76	$99,983	119,440
2019-11-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	0
2019-11-04	PENDARVIS DAVID	Chief Administrative Officer	Equity grant / award G	ResMed Common Stock	6,823	$0.00	$0	117,591
2019-11-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,367	$147.85	$645,661	124,414
2019-11-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	128,781
2019-11-01	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	22,555
2019-11-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$148.92	$119,136	87,046
2019-11-01	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	88,646
2019-10-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$145.95	$437,850	72,690
2019-10-28	Burt Carol	Dir	Equity grant / award G	ResMed Common Stock	695	$0.00	$0	23,478
2019-10-24	Douglas Robert Andrew	President and COO ResMed Inc.	Equity grant / award A	ResMed Common Stock	5,726	$0.00	$0	51,140
2019-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,302	$0.00	$0	0
2019-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	774	$130.25	$100,814	147,519
2019-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,302	$130.25	$430,086	45,414
2019-10-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,302	$43.63	$144,066	48,716
2019-10-14	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	26,600
2019-10-14	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$129.83	$863,493	304,324
2019-10-14	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	310,975
2019-10-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	4,367
2019-10-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,367	$128.62	$561,684	122,251
2019-10-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	126,618
2019-10-01	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,350	$135.13	$182,426	33,357
2019-09-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$134.14	$402,420	73,145
2019-09-16	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	3,302
2019-09-16	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	757	$131.63	$99,644	148,293
2019-09-16	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$131.63	$435,300	45,414
2019-09-16	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,721
2019-09-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	33,251
2019-09-09	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$137.38	$913,714	304,324
2019-09-09	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	310,975
2019-09-03	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	1,350	$138.11	$186,448	34,707
2019-08-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$139.21	$417,630	76,145
2019-08-20	TAYLOR RONALD R	Dir	Open-market sell S	ResMed Common Stock	4,429	$136.34	$603,863	19,855
2019-08-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	6,609
2019-08-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	763	$131.12	$100,045	149,050
2019-08-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$131.12	$433,614	45,414
2019-08-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,721
2019-08-14	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	17,987	$0.00	$0	304,324
2019-08-14	McHale Richard	President, RC Business	Equity grant / award A	ResMed Common Stock	7,195	$0.00	$0	18,410
2019-08-12	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	39,902
2019-08-12	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$132.35	$880,260	286,337
2019-08-12	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,988
2019-08-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	13,101
2019-08-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,367	$128.56	$561,422	117,883
2019-08-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	122,250
2019-08-01	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	24,955
2019-08-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$129.50	$103,600	76,623
2019-08-01	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	78,223
2019-07-30	WAREHAM JOHN P	Dir	Equity grant / award G	ResMed Common Stock	600	$0.00	$0	12,400
2019-07-29	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	12,306	$127.06	$1,563,563	11,215
2019-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	9,916
2019-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	804	$124.50	$100,098	149,813
2019-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$124.50	$411,722	45,414
2019-07-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,721
2019-07-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	46,553
2019-07-08	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$123.76	$823,128	286,337
2019-07-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,988
2019-07-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	17,468
2019-07-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	236	$124.40	$29,358	117,883
2019-07-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,131	$123.83	$511,529	118,119
2019-07-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	122,250
2019-07-01	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$123.17	$369,510	76,514
2019-06-17	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	13,223
2019-06-17	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	847	$118.44	$100,319	150,617
2019-06-17	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$118.44	$391,681	45,414
2019-06-17	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,721
2019-06-10	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	53,204
2019-06-10	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	5,211	$118.32	$616,576	286,337
2019-06-10	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	1,440	$117.56	$169,286	291,548
2019-06-10	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,988
2019-06-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	21,835
2019-06-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,367	$114.01	$497,882	117,883
2019-06-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	122,250
2019-06-03	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	24,838
2019-06-03	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$114.01	$91,208	78,223
2019-06-03	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	79,823
2019-05-31	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	239	$114.12	$27,275	117,883
2019-05-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$112.34	$337,020	79,514
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	23,629	$0.00	$0	0
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	9,628	$0.00	$0	0
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	11,085	$0.00	$0	9,628
2019-05-24	WAREHAM JOHN P	Dir	Open-market sell S	ResMed Common Stock	23,629	$114.00	$2,693,706	13,000
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M	ResMed Common Stock	23,629	$52.02	$1,229,181	36,629
2019-05-24	WAREHAM JOHN P	Dir	Open-market sell S	ResMed Common Stock	9,628	$114.00	$1,097,592	13,000
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M	ResMed Common Stock	9,628	$51.25	$493,435	22,628
2019-05-24	WAREHAM JOHN P	Dir	Open-market sell S	ResMed Common Stock	11,085	$113.44	$1,257,427	13,000
2019-05-24	WAREHAM JOHN P	Dir	Exercise / conversion M	ResMed Common Stock	11,085	$51.25	$568,106	24,085
2019-05-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	16,530
2019-05-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	893	$111.35	$99,436	151,464
2019-05-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$111.35	$368,234	45,414
2019-05-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,721
2019-05-13	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	59,855
2019-05-13	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	260	$110.25	$28,664	286,337
2019-05-13	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,391	$109.70	$701,086	286,597
2019-05-13	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,988
2019-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,367	$0.00	$0	26,202
2019-05-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,367	$112.58	$491,637	118,122
2019-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,367	$52.02	$227,171	122,579
2019-05-01	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	25,638
2019-05-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$104.51	$83,608	78,857
2019-05-01	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	80,457
2019-04-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$102.98	$308,940	82,390
2019-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	19,837
2019-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	978	$102.29	$100,040	152,357
2019-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$102.29	$338,273	45,297
2019-04-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,604
2019-04-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	66,506
2019-04-08	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$100.82	$670,554	286,282
2019-04-08	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,933
2019-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,457	$0.00	$0	0
2019-04-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,457	$105.21	$468,921	118,002
2019-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,457	$51.25	$228,421	122,459
2019-04-02	McHale Richard	President, RC Business	Exercise / conversion M · derivative	Resmed Stock Option Plan	21,616	$0.00	$0	0
2019-04-02	McHale Richard	President, RC Business	Exercise / conversion M · derivative	Resmed Stock Option Plan	4,907	$0.00	$0	0
2019-04-02	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	21,616	$105.00	$2,269,680	23,404
2019-04-02	McHale Richard	President, RC Business	Exercise / conversion M	ResMed Common Stock	21,616	$58.24	$1,258,916	45,020
2019-04-02	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	4,907	$105.00	$515,235	23,404
2019-04-02	McHale Richard	President, RC Business	Exercise / conversion M	ResMed Common Stock	4,907	$58.24	$285,784	28,311
2019-04-01	McHale Richard	President, RC Business	Exercise / conversion M · derivative	Resmed Stock Option Plan	1,079	$0.00	$0	21,616
2019-04-01	McHale Richard	President, RC Business	Exercise / conversion M · derivative	Resmed Stock Option Plan	244	$0.00	$0	4,907
2019-04-01	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	1,079	$105.05	$113,349	23,404
2019-04-01	McHale Richard	President, RC Business	Exercise / conversion M	ResMed Common Stock	1,079	$58.24	$62,841	24,483
2019-04-01	McHale Richard	President, RC Business	Open-market sell S	ResMed Common Stock	244	$105.05	$25,632	23,404
2019-04-01	McHale Richard	President, RC Business	Exercise / conversion M	ResMed Common Stock	244	$58.24	$14,211	23,648
2019-03-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	23,144
2019-03-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	991	$100.90	$99,992	153,335
2019-03-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$100.90	$333,676	45,297
2019-03-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	48,604
2019-03-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	73,157
2019-03-11	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$101.05	$672,084	286,282
2019-03-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,933
2019-03-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,457	$0.00	$0	4,457
2019-03-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,457	$103.61	$461,790	118,002
2019-03-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,457	$51.25	$228,421	122,459
2019-03-01	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	27,238
2019-03-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$102.80	$82,240	80,457
2019-03-01	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	82,057
2019-02-28	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$103.00	$309,000	88,390
2019-02-27	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	6,876	$0.00	$0	0
2019-02-27	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	6,876	$43.63	$300,000	45,297
2019-02-25	Sodhi Rajwant	President, SaaS Business	Open-market sell S	ResMed Common Stock	16,739	$101.50	$1,699,008	25,639
2019-02-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	26,451
2019-02-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	1,006	$99.95	$100,550	154,326
2019-02-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$99.95	$330,535	38,421
2019-02-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	41,728
2019-02-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,134	$0.00	$0	79,808
2019-02-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,517	$0.00	$0	0
2019-02-11	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	4,134	$97.22	$401,912	286,282
2019-02-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	4,134	$43.63	$180,366	290,416
2019-02-11	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	2,517	$97.11	$244,418	286,282
2019-02-11	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	2,517	$43.63	$109,817	288,799
2019-02-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,457	$0.00	$0	8,914
2019-02-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,457	$93.50	$416,730	118,002
2019-02-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,457	$51.25	$228,421	122,459
2019-02-01	Hollingshead James	President, Sleep Business	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	28,038
2019-02-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	800	$95.09	$76,072	82,089
2019-02-01	Hollingshead James	President, Sleep Business	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	83,689
2019-01-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$92.30	$276,900	91,390
2019-01-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	29,758
2019-01-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	881	$114.18	$100,593	155,332
2019-01-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$114.18	$377,593	38,421
2019-01-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	41,728
2019-01-14	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	6,651	$0.00	$0	2,517
2019-01-14	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	6,651	$113.75	$756,551	286,282
2019-01-14	Farrell Michael J.	Chief Executive Officer	Exercise / conversion M	ResMed Common Stock	6,651	$43.63	$290,183	292,933
2019-01-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,457	$0.00	$0	13,371
2019-01-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,457	$110.82	$493,925	118,002
2019-01-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,457	$51.25	$228,421	122,459
2019-01-02	Hollingshead James	President, Americas	Exercise / conversion M · derivative	ResMed Common Stock Options	800	$0.00	$0	28,838
2019-01-02	Hollingshead James	President, Americas	Open-market sell S	ResMed Common Stock	800	$112.13	$89,704	82,889
2019-01-02	Hollingshead James	President, Americas	Exercise / conversion M	ResMed Common Stock	800	$58.24	$46,592	84,489
2018-12-31	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$112.50	$337,500	96,390
2018-12-18	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	86	$106.94	$9,197	42,378
2018-12-18	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	77	$106.94	$8,234	42,464
2018-12-18	Sodhi Rajwant	President, SaaS Business	Other disposed transaction F	ResMed Common Stock	67	$106.94	$7,165	42,541
2018-12-17	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$112.56	$225,120	99,390
2018-12-13	FARRELL PETER C	Dir	Equity grant / award G	ResMed Common Stock	13,866	$115.39	$1,600,067	226,301
2018-12-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	4,455	$0.00	$0	17,828
2018-12-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	4,455	$112.09	$499,361	118,002
2018-12-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	4,455	$51.25	$228,319	122,457
2018-11-30	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	3,000	$110.50	$331,500	101,390
2018-11-27	Hollingshead James	President, Americas	Open-market sell S	ResMed Common Stock	5,893	$105.52	$621,829	75,121
2018-11-21	Farrell Michael J.	Chief Executive Officer	Other disposed transaction F	ResMed Common Stock	57,763	$104.18	$6,017,749	286,282
2018-11-21	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	103,558	$104.18	$10,788,672	344,045
2018-11-20	McHale Richard	President, RC Business	Other disposed transaction F	ResMed Common Stock	939	$106.94	$100,417	19,651
2018-11-20	McHale Richard	President, RC Business	Other disposed transaction F	ResMed Common Stock	1,149	$106.94	$122,874	20,590
2018-11-16	Farrell Michael J.	Chief Executive Officer	Open-market sell S	ResMed Common Stock	3,300	$104.49	$344,817	0
2018-11-16	Farrell Michael J.	Chief Executive Officer	Equity grant / award G	ResMed Common Stock	3,300	$0.00	$0	3,300
2018-11-16	Farrell Michael J.	Chief Executive Officer	Equity grant / award A	ResMed Common Stock	13,640	$0.00	$0	13,640
2018-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M · derivative	ResMed Common Stock Options	3,307	$0.00	$0	36,372
2018-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	984	$101.44	$99,817	109,222
2018-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Open-market sell S	ResMed Common Stock	3,307	$101.44	$335,462	55,805
2018-11-15	Douglas Robert Andrew	President and COO ResMed Inc.	Exercise / conversion M	ResMed Common Stock	3,307	$43.63	$144,284	59,112
2018-11-14	Drexler Karen	Dir	Equity grant / award A	ResMed Common Stock	2,533	$0.00	$0	5,524
2018-11-09	Douglas Robert Andrew	President and COO ResMed Inc.	Other disposed transaction F	ResMed Common Stock	5,994	$106.94	$640,998	55,805
2018-11-09	Douglas Robert Andrew	President and COO ResMed Inc.	Other disposed transaction F	ResMed Common Stock	2,018	$106.94	$215,805	61,799
2018-11-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	0
2018-11-05	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$105.97	$297,776	107,172
2018-11-05	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	109,982
2018-11-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	600	$105.93	$63,558	73,304
2018-10-29	Sodhi Rajwant	President, SaaS Business	Equity grant / award A	ResMed Common Stock	2,296	$0.00	$0	37,534
2018-10-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$103.16	$206,320	71,232
2018-10-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	2,810
2018-10-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$113.95	$320,200	104,251
2018-10-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	107,061
2018-10-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	600	$115.88	$69,528	70,623
2018-09-17	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$114.30	$228,600	73,232
2018-09-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	5,620
2018-09-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$111.26	$312,641	104,251
2018-09-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	107,061
2018-08-15	Sodhi Rajwant	President, SaaS Business	Equity grant / award A	ResMed Common Stock	8,512	$0.00	$0	35,238
2018-08-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	8,430
2018-08-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$106.20	$298,422	99,083
2018-08-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	101,893
2018-08-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	600	$105.93	$63,558	59,663
2018-07-16	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$109.01	$218,020	65,072
2018-07-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	11,240
2018-07-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$103.90	$291,959	99,083
2018-07-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	101,893
2018-07-02	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	600	$102.80	$61,680	60,263
2018-06-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$106.76	$213,520	67,072
2018-06-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	14,050
2018-06-04	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$103.75	$291,538	99,083
2018-06-04	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	101,893
2018-06-01	PENDARVIS DAVID	Chief Administrative Officer	Other disposed transaction F	ResMed Common Stock	167	$103.56	$17,295	99,083
2018-05-30	SULPIZIO RICHARD	Dir	Exercise / conversion M · derivative	ResMed Common Stock Options	28,403	$0.00	$0	0
2018-05-30	SULPIZIO RICHARD	Dir	Open-market sell S	ResMed Common Stock	28,403	$102.78	$2,919,260	7,420
2018-05-30	SULPIZIO RICHARD	Dir	Exercise / conversion M	ResMed Common Stock	28,403	$27.58	$783,355	35,823
2018-05-15	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$101.52	$203,040	69,072
2018-05-08	PACE GARY W	Dir	Exercise / conversion M · derivative	ResMed Stock Options	28,403	$0.00	$0	0
2018-05-08	PACE GARY W	Dir	Open-market sell S	ResMed Common Stock	28,403	$97.37	$2,765,600	100,578
2018-05-08	PACE GARY W	Dir	Exercise / conversion M	ResMed Common Stock	28,403	$27.58	$783,355	128,981
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,922	$0.00	$0	0
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	1,951	$0.00	$0	0
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	16,860
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	1,922	$52.02	$99,982	99,106
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	1,951	$51.25	$99,989	97,184
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$95.91	$269,507	95,233
2018-05-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	98,043
2018-05-01	Hollingshead James	President, Sleep Business	Open-market sell S	ResMed Common Stock	600	$94.69	$56,814	61,261
2018-04-19	PENDARVIS DAVID	Chief Administrative Officer	Equity grant / award A	ResMed Common Stock	780	$0.00	$0	95,233
2018-04-16	Sandercock Brett	Chief Financial Officer	Open-market sell S	ResMed Common Stock	2,000	$99.36	$198,720	71,072
2018-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M · derivative	ResMed Common Stock Options	2,810	$0.00	$0	19,670
2018-04-03	PENDARVIS DAVID	Chief Administrative Officer	Open-market sell S	ResMed Common Stock	2,810	$96.19	$270,294	94,453
2018-04-03	PENDARVIS DAVID	Chief Administrative Officer	Exercise / conversion M	ResMed Common Stock	2,810	$38.98	$109,534	97,263

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count